“Escitalopram-Induced Hyponatremia and Neurological Adverse Effects: A Case Series”, Int. J. of Res. in Pharmacology &Pharmacotherapeutics , vol. 14, no. 1, pp. 161–166, Mar. 2025, doi: 10.61096/ijrpp.v14.iss1.2025.161-166.